<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite great interest in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemoprevention, effective agents are few </plain></SENT>
<SENT sid="1" pm="."><plain>Here we show that <z:chebi fb="3" ids="3638">chloroquine</z:chebi>, a drug that activates the stress-responsive Atm-p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor pathway, preferentially enhances the <z:hpo ids='HP_0011420'>death</z:hpo> of Myc oncogene-overexpressing primary mouse B cells and mouse embryonic fibroblasts (MEFs) and impairs Myc-induced <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> in a transgenic mouse model of human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="3638">Chloroquine</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> in primary MEFs and human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells was dependent upon p53, but not upon the p53 modulators Atm or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Accordingly, <z:chebi fb="3" ids="3638">chloroquine</z:chebi> impaired spontaneous <z:hpo ids='HP_0002665'>lymphoma</z:hpo> development in Atm-deficient mice, a mouse model of <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo>, but not in p53-deficient mice </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="3" ids="3638">Chloroquine</z:chebi> treatment enhanced markers of both macroautophagy and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in MEFs but ultimately impaired lysosomal protein degradation </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, <z:chebi fb="3" ids="3638">chloroquine</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> was not dependent on caspase-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, as neither overexpression of the antiapoptotic protein Bcl-2 nor deletion of the proapoptotic Bax and Bak affected <z:chebi fb="3" ids="3638">chloroquine</z:chebi>-induced MEF <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>However, when both apoptotic and autophagic pathways were blocked simultaneously, <z:chebi fb="3" ids="3638">chloroquine</z:chebi>-induced killing of Myc-overexpressing cells was blunted </plain></SENT>
<SENT sid="7" pm="."><plain>Thus <z:chebi fb="3" ids="3638">chloroquine</z:chebi> induces lysosomal stress and provokes a p53-dependent cell <z:hpo ids='HP_0011420'>death</z:hpo> that does not require caspase-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>These findings specifically demonstrate that intermittent <z:chebi fb="3" ids="3638">chloroquine</z:chebi> use effectively prevents <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in mouse models of 2 genetically distinct human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> syndromes, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo>, suggesting that agents targeting lysosome-mediated degradation may be effective in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention </plain></SENT>
</text></document>